Professor Larry Fleckenstein was awarded a subcontract with Case Western Reserve University for his project, “Pharmacodynamics and Pharmacokinetics Studies for Triple Drug Therapy to Treat Human Lymphatic Filariasis (LF): Diethylcarbamize (DEC), Albendazole (ALB) and Ivermectin (IVM) to Measure and Analyze Drug Levels”.